We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+16.98%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$295B
AUM Growth
+$35.4B
(+14%)
Cap. Flow
-$1.58B
Cap. Flow
% of AUM
-0.53%
Top 10 Holdings %
Top 10 Hldgs %
22.42%
Holding
3,425
New
145
Increased
1,798
Reduced
1,253
Closed
125
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1B |
| 2 |
Apple
AAPL
|
+$797M |
| 3 |
Merck
MRK
|
+$316M |
| 4 |
Amazon
AMZN
|
+$308M |
| 5 |
Medtronic
MDT
|
+$298M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$587M |
| 2 |
NXP Semiconductors
NXPI
|
+$554M |
| 3 |
Meta Platforms (Facebook)
META
|
+$449M |
| 4 |
Intuit
INTU
|
+$433M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.73% |
| 2 | Healthcare | 13.29% |
| 3 | Consumer Discretionary | 13.23% |
| 4 | Financials | 12.2% |
| 5 | Communication Services | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
IDEAYA Biosciences
IDYA
$3.56B
| $1.16M | ﹤0.01% |
82,508
+16,130
| +24% | +$219K |
|
|
CSTR
2727
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $1.15M | ﹤0.01% |
78,233
+13,238
| +20% | +$159K |
|
2728
Limoneira
LMNR
$251M
| $1.14M | ﹤0.01% |
68,473
-322
| -0.5% | -$4.84K |
|
|
ATHX
2729
DELISTED
Athersys, Inc. Common Stock
ATHX
| $1.14M | ﹤0.01% |
25,976
+356
| +1% | +$16.2K |
|
2730
iShares MSCI ACWI ex US ETF
ACWX
$11.8B
| $1.13M | ﹤0.01% |
21,300
| – | – |
|
2731
Citizens & Northern Corp
CZNC
$455M
| $1.13M | ﹤0.01% |
56,809
+8,158
| +17% | +$150K |
|
2732
Dianthus Therapeutics
DNTH
$6.09B
| $1.13M | ﹤0.01% |
8,979
+949
| +12% | +$108K |
|
2733
Atomera
ATOM
$214M
| $1.13M | ﹤0.01% |
69,930
+9,781
| +16% | +$102K |
|
2734
Cadiz
CDZI
$291M
| $1.13M | ﹤0.01% |
105,630
+7,313
| +7% | +$73.3K |
|
|
VOXX
2735
DELISTED
VOXX International Corporation Class A
VOXX
| $1.12M | ﹤0.01% |
87,959
-6,528
| -7% | -$76.3K |
|
|
FPI
2736
Farmland Partners
FPI
$432M
| $1.12M | ﹤0.01% |
128,995
+6,302
| +5% | +$47.7K |
|
|
VXRT
2737
DELISTED
Vaxart
VXRT
| $1.12M | ﹤0.01% |
196,356
-4,230
| -2% | -$26.9K |
|
2738
LifeVantage
LFVN
$85.3M
| $1.11M | ﹤0.01% |
119,446
-2,915
| -2% | -$32.7K |
|
|
DMTK
2739
DELISTED
DermTech, Inc. Common Stock
DMTK
| $1.11M | ﹤0.01% |
34,307
+8,240
| +32% | +$117K |
|
2740
SmartFinancial
SMBK
$888M
| $1.11M | ﹤0.01% |
61,281
+8,004
| +15% | +$132K |
|
2741
Ezcorp Inc
EZPW
$1.71B
| $1.11M | ﹤0.01% |
231,589
+17,987
| +8% | +$90.4K |
|
2742
Regis Corp
RGS
$70.2M
| $1.11M | ﹤0.01% |
6,016
-5,061
| -46% | -$771K |
|
|
ONT
2743
Onterris Inc
ONT
$580M
| $1.1M | ﹤0.01% |
35,711
+4,448
| +14% | +$126K |
|
2744
RBB Bancorp
RBB
$455M
| $1.1M | ﹤0.01% |
71,892
+6,679
| +10% | +$94.8K |
|
2745
Funko
FNKO
$328M
| $1.1M | ﹤0.01% |
105,996
-486
| -0.5% | -$4.01K |
|
|
PRVL
2746
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
| $1.1M | ﹤0.01% |
87,660
-13,686
| -14% | -$173K |
|
2747
Anavex Life Sciences
AVXL
$310M
| $1.09M | ﹤0.01% |
201,692
+1,605
| +0.8% | +$8.46K |
|
2748
Greenlight Captial
GLRE
$506M
| $1.08M | ﹤0.01% |
148,011
+12,298
| +9% | +$91K |
|
|
INBX
2749
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $1.08M | ﹤0.01% |
+32,818
| New | +$873K |
|
|
ROCC
2750
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $1.08M | ﹤0.01% |
106,257
+40,308
| +61% | +$380K |
|
Similar funds
VFT
Nuveen's Q4 2020 Portfolio in Review
As of Q4 2020, Nuveen held 3,425 positions worth $295B, up 14% from $260B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Nuveen's Q4 2020 filing shows 145 new, 1,798 increased, 1,253 reduced and 125 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M. The largest sale was Walt Disney, an estimated $587M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Nuveen's largest Q4 2020 buy was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M.
- Nuveen added most to Microsoft in Q4 2020, an estimated $1B increase.
- Nuveen's biggest Q4 2020 reduction was Walt Disney, cutting an estimated $587M.
- Nuveen fully exited Alcon in Q4 2020, selling an estimated $174M.
- Nuveen's ten largest holdings make up 22% of its $295B portfolio in Q4 2020.
- Nuveen opened 145 new positions and closed 125 in Q4 2020.
- Nuveen's portfolio value rose 14% quarter-over-quarter to $295B.
Based on Nuveen's 13F filing for Q4 2020, filed 16 Feb 2021.